Drugs developed for the treatment of diabetes such as semaglutide (marketed as Ozempic or Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro or Zepbound) are being used to decrease the weight of obesity risks:
- FR
- EN
4293 results
-
-
-
-
-
Our expertsHelen joined SCOR as Head of Underwriting for Life and Health in the UK & Ireland in July 2024.
-
Press ReleasesFollowing the acquisition, SCOR intends to file a simplified public tender offer
-
Our expertsAs a former Senior Vice President and now Head of US Financial Solutions, Brian leads the Financial Solutions team which uses reinsurance applicati
-
-
-
NewsOctober 3, 2024State-of-the-art machine learning engine provides risk scoring for underwriting and claims
-
-
